Pottasium phosphate intravenous guidline
Reading File
Finding Sources
Finding Sources
Searching the Web
IV potassium phosphate intravenous administration guideline dose rate hypophosphatemia 2024
Reading File
Reading File
Reading File
Reading File
Searching PubMed
intravenous phosphate replacement hypophosphatemia protocol
I now have comprehensive information from multiple authoritative sources. Here is the complete IV potassium phosphate guideline:
Intravenous Potassium Phosphate - Clinical Guideline
Formulation
Potassium phosphate injection is a concentrated solution containing:
- Phosphorus: 3 mmol/mL (93 mg/mL)
- Potassium: 4.4 mEq/mL (170 mg/mL)
Critical Safety Warning: Never administer undiluted or as IV push. Rapid or undiluted administration has caused cardiac arrest, arrhythmia (including QT prolongation), hypotension, hyperkalemia, seizures, and death. Must always be diluted and given by slow infusion.
Indications
- Symptomatic or severe hypophosphatemia (serum phosphorus <1.0 mg/dL)
- Combined hypokalemia + hypophosphatemia (e.g., diabetic ketoacidosis)
- TPN supplementation when oral route is unavailable
- Phosphorus replacement in patients unable to tolerate oral therapy
Pre-Administration Assessment
Before giving IV potassium phosphate, check:
| Parameter | Action |
|---|---|
| Serum phosphorus | Determines dose tier |
| Serum potassium | If K+ ≥4.0 mEq/L - switch to sodium phosphate instead |
| Serum calcium | Contraindicated if hypercalcemia; monitor for hypocalcemia post-infusion |
| Renal function | Reduce dose by 50% if CrCl <20 mL/min; contraindicated in severe renal insufficiency |
| Serum magnesium | Correct concurrent hypomagnesemia (refractory otherwise) |
Dosing for Hypophosphatemia
Adult Doses
| Serum Phosphorus Level | IV Dose | Infusion Duration |
|---|---|---|
| <0.5 mg/dL (severe) | 0.5 mmol/kg | Over 4-6 hours |
| 0.5-1.0 mg/dL (moderate-severe) | 0.25 mmol/kg | Over 4-6 hours |
| Goldman-Cecil alternative | 0.16-0.64 mmol/kg | Over 4-8 hours |
| Barash Clinical Anesthesia | 0.2-0.68 mmol/kg (5-16 mg/kg) | Over 12 hours |
Maximum single dose: Phosphorus 45 mmol (= potassium ~66-71 mEq) per infusion.
TPN supplementation: 20-40 mmol/day IV admixed in parenteral nutrition (titrate to levels).
Pediatric Doses
- Same weight-based dosing as adults (0.25-0.5 mmol/kg based on severity)
- Caution in premature neonates - risk of aluminum toxicity from the formulation
Infusion Rate
| Setting | Maximum Rate |
|---|---|
| Standard | Phosphorus 6.4 mmol/hr (potassium 10 mEq/hr) through peripheral catheter |
| ICU/Central line | 15 mmol/100 mL NS or D5W over 2 hours centrally |
| Combined severe hypokalemia + hypophosphatemia (DKA) | <50 mmol over 8 hours to prevent hypocalcemia and metastatic calcification |
Dilution / Preparation
| Setting | Preparation |
|---|---|
| General ward | KPhos 15 mmol in 250 mL NS or D5W |
| ICU (central access) | KPhos 15 mmol in 100 mL NS or D5W |
| TPN | Admix in parenteral nutrition bag |
- Do not use dextrose vehicle if also correcting hypokalemia (dextrose stimulates insulin and drops K+)
- Peripheral infusion: concentration should not exceed 60 mEq K+/L to avoid vein irritation
Monitoring During and After Infusion
- Check serum phosphorus, potassium, calcium, and magnesium before administration
- Recheck phosphorus at end of infusion and before any repeat dose
- Continuous ECG monitoring if infusing at rates exceeding 10 mEq/hr of potassium
- Monitor for signs of hypocalcemia (tetany, neuromuscular irritability, QT prolongation)
- Reassess renal function in patients with pre-existing kidney disease
Complications
| Complication | Mechanism |
|---|---|
| Hypocalcemia / tetany | Calcium-phosphate precipitation |
| Metastatic calcification | CaPO4 deposition in soft tissues |
| Hyperkalemia | From potassium load |
| Hyperphosphatemia | Overzealous replacement |
| Hypotension | Rapid infusion |
| Acute kidney injury | Nephrocalcinosis |
| Cardiac arrhythmia | Electrolyte shifts |
When to Use Sodium Phosphate Instead
Switch to sodium phosphate IV when:
- Serum potassium is ≥4.0 mEq/L (to avoid further hyperkalemia)
- Patient has renal tubular acidosis with concurrent hyperkalemia
- Potassium load is otherwise contraindicated
Special Populations
- Renal impairment (CrCl <20 mL/min): Reduce dose by 50%; monitor closely
- DKA: IV potassium phosphate appropriate when both hypokalemia and hypophosphatemia are present; combine with potassium chloride as needed; infuse at <50 mmol/8 hours
- Continuous venovenous hemodiafiltration (CVVHDF): Consider phosphate-containing dialysate/replacement fluid instead
- Hepatic failure: Hypophosphatemia may indicate hepatic regeneration; correct via IV phosphate
Sources: Barash Clinical Anesthesia 9e, p. 1243-1244; Goldman-Cecil Medicine (International Ed.), p. 1238; Brenner and Rector's The Kidney, p. 764; FDA Prescribing Information for Potassium Phosphates Injection; RxList Dosing Reference
This is a shared conversation. Sign in to Orris to start your own chat.